Comparative Effectiveness of Vancomycin vs. Metronidazole in Mild Clostridium difficile Infections, and Potential Impact on Subsequent Vancomycin-Resistant Enterococcus (VRE) Isolation

BACKGROUND: The epidemiology and clinical characteristics of Clostridium difficile infections (CDI) have evolved dramatically in the past decade. Vancomycin is the treatment of choice for moderate to severe CDI, with superior cure rates observed in comparative trials. However, controlled comparative...

Descripción completa

Detalles Bibliográficos
Autores principales: Youngster, Ilan, Lazarovitch, Zipora, Bondorenco, Marina, Mengesha, Betlehem, Toledano, Limor, Kachlon, Yael, Marchaim, Dror
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631449/
http://dx.doi.org/10.1093/ofid/ofx163.966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631449/
http://dx.doi.org/10.1093/ofid/ofx163.966

Ejemplares similares